Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Hair follicles prevent NK cell attacks to avoid hair loss.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Stem cells regenerate tissues and their behavior varies by environment, suggesting the hematopoietic system model may need revision.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.